Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies

S Conti1, F Fanti, W Magliani

  • 1Istituto di Microbiologia, Facoltà di Medicina e Chirurgia, Università degli Studi di Parma, Italy.

Insights

Novel candidacidal antibodies demonstrated lethal effects against multidrug-resistant Mycobacterium tuberculosis. This discovery offers a promising new immunotherapeutic strategy for tuberculosis treatment.

Area of Science:

  • Immunology
  • Microbiology
  • Biotechnology

Background:

  • Antibiotic resistance in Mycobacterium tuberculosis poses a significant global health threat.
  • The yeast Pichia anomala killer toxin (KT) exhibits broad-spectrum antibiotic activity.
  • Internal image antibodies targeting KT were previously characterized.

Purpose of the Study:

  • To investigate the efficacy of candidacidal antibodies against a multidrug-resistant Mycobacterium tuberculosis isolate.
  • To explore the potential of these antibodies as an immunotherapeutic approach for tuberculosis.

Main Methods:

  • Production of human natural (KTAb), murine monoclonal (KTMAb), and single-chain recombinant (KTScFv) candidacidal antibodies.
  • Testing the antibodies' lethal effect on a KT-sensitive multidrug-resistant Mycobacterium tuberculosis isolate.
  • Assessing antibody binding to bacterial cell surfaces and inhibition by specific absorption.

Main Results:

  • KTAb, KTMAb, and KTScFv exhibited a lethal effect against the multidrug-resistant Mycobacterium tuberculosis isolate.
  • Mycobactericidal activity correlated with antibody binding to the bacterial cell surface.
  • Binding was specifically inhibited by absorption with MAb KT4.

Conclusions:

  • Candidacidal antibodies targeting the Pichia anomala killer toxin internal image show potent activity against multidrug-resistant Mycobacterium tuberculosis.
  • These findings suggest a novel and potentially effective immunotherapeutic strategy for tuberculosis.

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...